Descripción

Clinical response data comparing sodium butyrate versus placebo as add-on therapy in pediatric IBD patients track changes in disease activity scores over the intervention period.

Figure 2

Chart

Source Paper

Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases-Randomized Placebo-Controlled Multicenter Trial.

Nutrients (2022)

PMID: 36014789

DOI: 10.3390/nu14163283

Cite This Figure

![Figure 2: Clinical response data comparing sodium butyrate versus placebo as add-on therapy in pediatric IBD patients track changes in disease activity scores over the intervention period.]()

> Source: Anna Pietrzak et al. "Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed I." *Nutrients*, 2022. PMID: [36014789](https://pubmed.ncbi.nlm.nih.gov/36014789/)

<figure>
  <img src="" alt="Clinical response data comparing sodium butyrate versus placebo as add-on therapy in pediatric IBD patients track changes in disease activity scores over the intervention period." />
  <figcaption>Figure 2. Clinical response data comparing sodium butyrate versus placebo as add-on therapy in pediatric IBD patients track changes in disease activity scores over the intervention period.<br>  Source: Anna Pietrzak et al. "Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed I." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36014789/">36014789</a></figcaption>
</figure>

Evidencia relacionada

Butyrate (Sodium/Calcium Butyrate) para Ulcerative Colitis (UC)

Calificación C · 3 estudios

Butyrate (Sodium/Calcium Butyrate) para Crohn's Disease

Calificación C · 2 estudios